Kestra Medical Technologies Ltd. (KMTS) Price & Analysis

Compare

9 Followers

KMTS Stock Chart & Stats

Day’s Range― - ―

52-Week Range$13.25 - $26.15

Previous CloseN/A

VolumeN/A

Average Volume (3M)352.33K

Market Cap

$819.52M

Enterprise Value$1.04B

Total Cash (Recent Filing)$237.59M

Total Debt (Recent Filing)$44.31M

Price to Earnings (P/E)―

Beta0.80

Next Earnings

Apr 20, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-2.21

Shares Outstanding51,348,656

10 Day Avg. Volume266,402

30 Day Avg. Volume352,327

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)N/A

Price to Sales (P/S)N/A

P/FCF RatioN/A

Enterprise Value/Market Cap1.27

Enterprise Value/Revenue32.24

Enterprise Value/Gross Profit73.50

Enterprise Value/Ebitda-15.92

Forecast

1Y Price Target

$24.58

Price Target Upside54.01% Upside

Rating ConsensusModerate Buy

Number of Analyst Covering6

Bulls Say, Bears Say

Bulls Say

Future GuidanceFY2026 guidance of $85m was set $2m above the Street’s current estimate of $83m.

Market ExpansionKestra has seen a 120% increase in prescription rates at some accounts after adopting ASSURE, indicating market expansion.

Revenue Growth4QFY25 revenue of $17.2 million increased 71% YoY and came in +10% ahead of consensus data.

Bears Say

Adjusted EBITDAA 4Q adjusted EBITDA loss of $20.3 million was greater than expected, reflecting higher investment into the company’s commercial strategy.

Operating ExpensesOperating expense in FQ4 was slightly higher than expected due to public company costs and investments in the commercial organization following the hiring of the Chief Commercial Officer.

Kestra Medical Technologies Ltd. News

RxSight appoints Raymond Cohen to its board of directors

RxSight (RXST) announced the appointment of Raymond Cohen to its Board of Directors. Cohen currently serves on the...

13d ago

KMTS

RXST

Kestra Medical Technologies Ltd.: Balanced Hold Rating Amid Revenue Growth and EBITDA Challenges

Goldman Sachs analyst David Roman maintained a Hold rating on Kestra Medical Technologies Ltd. today and set a...

1M ago

KMTS

Kestra Medical Technologies Reports Strong Revenue Growth

Kestra Medical Technologies Ltd. ( ($KMTS) ) has released its Q4 earnings. Here is a breakdown of the...

1M ago

KMTS

Closing Bell Movers: Victory Capital gains on S&P 400 inclusion

In the opening 90 minutes of the evening session, U.S. equity futures are down slightly with a 0.2%...

1M ago

BHF

BLK

Kestra Medical reports Q4 EPS ($2.21) vs. ($1.22) last year

Reports Q4 revenue $17.23M, consensus $15.67M. “We capped an exciting year for Kestra with a very strong finish...

1M ago

KMTS

Kestra Medical sees FY26 revenue $85M, consensus $82.91M

Webster continued, “In fiscal year 2025, the ASSURE(R) system protected thousands of patients from sudden cardiac arrest, a...

1M ago

KMTS

KMTS Earnings this Week: How Will it Perform?

Kestra Medical Technologies Ltd. (KMTS) is scheduled to report 4th quarter earnings on 07/15/2025, after the market closes....

1M ago

KMTS

Kestra Medical announces inclusion in Russell 2000, Russell 3000 Indexes

Kestra Medical (KMTS) Technologies announced that the company will be added to the Russell 3000 Index, with automatic...

2M ago

KMTS

Kestra Medical Appoints Conor Hanley to Board

Kestra Medical Technologies Ltd. ( ($KMTS) ) just unveiled an announcement. On June 4, 2025, Kestra Medical Technologies...

2M ago

KMTS

Kestra Medical appoints Conor Hanley to board of directors

Kestra Medical (KMTS) Technologies announced the appointment of Conor Hanley as an independent director to its board, effective...

2M ago

KMTS

Optimistic Buy Rating for Kestra Medical Technologies Ltd. Driven by Strategic Expansion and Promising Financial Outlook

Kestra Medical Technologies Ltd. (KMTS – Research Report), the Healthcare sector company, was revisited by a Wall Street...

3M ago

KMTS

Kestra Medical showcases real-world outcomes for ASSURE WCD

Kestra Medical (KMTS) Technologies announced the presentation of new real-world data on the ASSURE Wearable Cardioverter Defibrillator at...

4M ago

KMTS

Kestra Medical to exhibit at Heart Rhythm 2025

Kestra Medical (KMTS) Technologies will exhibit at Heart Rhythm 2025, the annual meeting of the Heart Rhythm Society,...

4M ago

KMTS

Investors Turn Bullish on Kestra Medical Technologies Stock (KMTS) After Tepid Q3 Response

Kestra Medical Technologies ($KMTS) saw a positive response in its shares after reporting Q3 results. The company announced...

4M ago

KMTS

KMTS FAQ

What was Kestra Medical Technologies Ltd.’s price range in the past 12 months?

Kestra Medical Technologies Ltd. lowest stock price was $13.25 and its highest was $26.15 in the past 12 months.

What is Kestra Medical Technologies Ltd.’s market cap?

Kestra Medical Technologies Ltd.’s market cap is $819.52M.

When is Kestra Medical Technologies Ltd.’s upcoming earnings report date?

Kestra Medical Technologies Ltd.’s upcoming earnings report date is Apr 20, 2026 which is in 246 days.

How were Kestra Medical Technologies Ltd.’s earnings last quarter?

Kestra Medical Technologies Ltd. released its earnings results on Jul 15, 2025. The company reported -$2.21 earnings per share for the quarter, missing the consensus estimate of -$0.525 by -$1.685.

Is Kestra Medical Technologies Ltd. overvalued?

According to Wall Street analysts Kestra Medical Technologies Ltd.’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Kestra Medical Technologies Ltd. pay dividends?

Kestra Medical Technologies Ltd. does not currently pay dividends.

What is Kestra Medical Technologies Ltd.’s EPS estimate?

Kestra Medical Technologies Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Kestra Medical Technologies Ltd. have?

Kestra Medical Technologies Ltd. has 51,348,656 shares outstanding.

What happened to Kestra Medical Technologies Ltd.’s price movement after its last earnings report?

Kestra Medical Technologies Ltd. reported an EPS of -$2.21 in its last earnings report, missing expectations of -$0.525. Following the earnings report the stock price went down -5.77%.

Which hedge fund is a major shareholder of Kestra Medical Technologies Ltd.?

Currently, no hedge funds are holding shares in KMTS

Kestra Medical Technologies Ltd. Stock Smart Score

Neutral

Analyst Consensus

Moderate Buy

Average Price Target:
$24.58 (54.01% Upside)

News Sentiment

Neutral

Bullish news 59%
Bearish news 100%

Fundamentals

Return on Equity

-130.38%

Trailing 12-Months

Asset Growth

485.10%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Kestra Medical Technologies Ltd.

Kestra Medical Technologies Ltd. (KMTS) is a healthcare company that focuses on developing and providing innovative medical devices aimed at improving patient care and outcomes. The company operates primarily in the medical technology sector, offering advanced solutions for monitoring and managing chronic health conditions. Kestra Medical Technologies is known for its commitment to leveraging cutting-edge technology to enhance patient safety and healthcare efficiency.

Kestra Medical Technologies Ltd. (KMTS) Earnings & Revenues

Historic Earnings Reports

KMTS Earnings Call

Q4 2025

0:00 / 0:00

KMTS Stock 12 Month Forecast

Average Price Target

$24.58

▲(54.01% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"14":"$14","31":"$31","18.25":"$18.25","22.5":"$22.5","26.75":"$26.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":30,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$30.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.58,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$24.58</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":15.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$15.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[14,18.25,22.5,26.75,31],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2024","6":"Mar<br/>2025","9":"May<br/>2025","12":"Aug<br/>2025","25":"Aug<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.38,16.504615384615384,17.62923076923077,18.753846153846155,19.87846153846154,21.003076923076925,22.127692307692307,23.252307692307692,24.376923076923077,25.501538461538463,26.626153846153848,27.75076923076923,28.87538461538462,{"y":30,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.38,16.087692307692308,16.795384615384616,17.503076923076925,18.21076923076923,18.91846153846154,19.626153846153848,20.333846153846153,21.04153846153846,21.74923076923077,22.456923076923076,23.164615384615384,23.872307692307693,{"y":24.58,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.38,15.38923076923077,15.39846153846154,15.407692307692308,15.416923076923078,15.426153846153847,15.435384615384615,15.444615384615386,15.453846153846154,15.463076923076922,15.472307692307693,15.481538461538461,15.490769230769232,{"y":15.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":20.99,"date":1725148800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1727740800000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1730419200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1733011200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1735689600000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1738368000000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1740787200000,"info":"<div class=\"mt2 colorgray-1\">\n          No historical consensus available\n      </div>","marker":{"enabled":true,"symbol":"circle"}},{"y":20.99,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":24.58,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":22.96,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.68,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.84,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.38,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >